PTC Therapeutics (PTCT) earnings, Oct 29, 2026: EPS −410%, stock +2.3%
In brief
PTC Therapeutics reported on Oct 29, 2026. Earnings per share changed −410% year over year, 532.4% below the estimate; revenue +70%. The stock opened with a +0.8% gap and closed the day +2.3% (Oct 29, 2026). The stock is now 27.7% below its 52-week high, −8.5% over 12 months. Next report: Feb 23, 2027.
EPS vs estimate−532.4%
EPS, YoY−410%
Revenue, YoY+70%
Gap · day+0.8% · +2.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −6.1% | −9.9% |
| Oct 29, 2026 | +0.8% | +2.3% |
Next-quarter estimates, ratings and the PTCT chart are in the terminal.
Open the terminalFAQ
When is PTC Therapeutics's next earnings report?
Feb 23, 2027. The date comes from daily data and is corrected if the company moves it.
How did PTC Therapeutics stock react to the report?
Opening gap +0.8%, day's result +2.3%.
Did PTC Therapeutics's earnings grow?
Earnings per share fell 410% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.